Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Cash & Current Investments: 2016-2019

Historic Cash & Current Investments for Monopar Therapeutics (MNPR) over the last 4 years, with Dec 2019 value amounting to $13.2 million.

  • Monopar Therapeutics' Cash & Current Investments rose 300.10% to $18.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $56.3 million, marking a year-over-year increase of 151.52%. This contributed to the annual value of $13.2 million for FY2019, which is 91.71% up from last year.
  • As of FY2019, Monopar Therapeutics' Cash & Current Investments stood at $13.2 million, which was up 91.71% from $6.9 million recorded in FY2018.
  • In the past 5 years, Monopar Therapeutics' Cash & Current Investments ranged from a high of $13.2 million in FY2019 and a low of $2.9 million during FY2016.
  • Moreover, its 3-year median value for Cash & Current Investments was $9.8 million (2017), whereas its average is $10.0 million.
  • In the last 5 years, Monopar Therapeutics' Cash & Current Investments skyrocketed by 240.48% in 2017 and then decreased by 29.54% in 2018.
  • Monopar Therapeutics' Cash & Current Investments (Yearly) stood at $2.9 million in 2016, then spiked by 240.48% to $9.8 million in 2017, then decreased by 29.54% to $6.9 million in 2018, then skyrocketed by 91.71% to $13.2 million in 2019.